Media & Investors

We’re committed to transparency – access our key documents and share price, all in one place.

Investor Overview

Growing with Kuros

  • Successful launch of MagnetOsTM MIS Delivery System
  • EU MDR certification for MagnetOs to support long-term availability
  • Geographic expansion with multiple international approvals

  • Total revenue reached USD 146 million
  • Sales increased 72% year-over-year
  • Expansion into the extremities market

  • Debt free and robust cash position of USD 19.8 million
  • Adjusted EBITDA margin of 13.4%
  • First year with net profit (USD 2.6 million)

Financial Data

Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.

Annual Reports

Interim Results

Presentations

Shareholder Meetings

Different persons hand holding a globe striving for Accessibility

Striving for sustainability

Our commitment to people & planet

Kuros is deeply committed to a sustainable future for all.

Today, Environmental, Social, and Governance (ESG) principles are increasingly guiding how we operate — from sustainable manufacturing to community engagement.

While we are in the early stages of formalizing our ESG framework, we are actively evaluating and implementing strategies to align our operations with these principles.